Search
Galmed Pharmaceuticals Ltd
GLMDAdd to Watchlist
0.613USD
+0.014+2.32%
Close 07-31 16:00（ET）Quotes delayed by 15 min
4.03MMarket Cap
LossP/E TTM
Galmed Pharmaceuticals Ltd's Company Valuation
Currency: USD Updated: 2026-07-31The current valuation score of Galmed Pharmaceuticals Ltd is 8.63, ranking 78 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -0.26, which is -46.78% below the recent high of -0.14 and -6616.02% above the recent low of -17.44.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.